Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reliability of second trimester triple screening for Down syndrome in rhesus-negative women

Abstract

Objective:

To find out whether there is considerable influence on second trimester serum concentrations owing to the rhesus status.

Study design:

This retrospective cohort study was performed at the Perinatology Unit of the GATA Haydarpasa Teaching Hospital. During the study interval, 2265 pregnancies met inclusion criteria. The blood samples were collected in 117 pregnancies with a maternal rhesus-negative blood group status. The control group consisted of 2148 pregnancies with a maternal rhesus-positive blood group status. Statistical analysis was performed by SPSS 11.0 statistical software.

Results:

Pregnancies with a maternal rhesus-negative blood group status were identified in 117 patients. The overall prevalence of pregnancies with a maternal rhesus-negative blood group status were 5.1% in our study. Only unconjugated estriol multiples of the median values were significantly decreased in rhesus-negative women (P<0.001). Alpha-fetoprotein and human chorionic gonadotrophin multiples of the median values did not differ significantly (P>0.05).

Conclusion:

We conclude that if second trimester screening test to be used in Rh negative pregnancies, either the corrected value should be referred or double test result should be considered ignoring the unconjugated estriol result. Another option is the first trimester Down syndrome screening test.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE . An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984; 148: 886–894.

    Article  CAS  Google Scholar 

  2. Cuckle HS, Wald NJ, Lindenbaum RH . Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1984; 1: 926–929.

    Article  CAS  Google Scholar 

  3. Canick JA, Palomaki GE, Osthanondh R . Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990; 10: 546–548.

    Article  CAS  Google Scholar 

  4. Bogart MH, Pandian MR, Jones OW . Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987; 7: 623–630.

    Article  CAS  Google Scholar 

  5. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Saller DN, Panizza DS . Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alphafetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1992; 12: 925–930.

    Article  CAS  Google Scholar 

  6. Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA et al. Risk-based prenatal screening for trisomy 18 using alphafetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1995; 15: 713–723.

    Article  CAS  Google Scholar 

  7. Bartels I, Hoppe-Sievert B, Bockel B, Herold S, Caesar J . Adjustment formulae for maternal serum alphafetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weigth and smoking. Prenat Diagn 1993; 13: 123–130.

    Article  CAS  Google Scholar 

  8. Crandall BF, Lebherz TB, Schroth PC, Matsumoto M . Alphafetoprotein concentrations in maternal serum: relation to race and body weight. Clin Chem 1983; 29 (3): 531–533.

    CAS  PubMed  Google Scholar 

  9. Wald N, Cuckle H, Wu T, George L . Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Br J Obstet Gynaecol 1991; 98: 905–908.

    Article  CAS  Google Scholar 

  10. Wald NJ, Cuckle H, Boreham J, Stirrat GM, Turnbull AC . Maternal serum alpha-fetoprotein and diabetes mellitus. Br J Obstet Gynaecol 1979; 86: 101–105.

    Article  CAS  Google Scholar 

  11. Daniel DG, Reynolds T, Penney MD . Calculation of Down's syndrome risk. Lancet 1994; 343: 490.

    Article  CAS  Google Scholar 

  12. Zimmermann R, Streicher A, Huch R, Huch A . Effect of gravidity and parity on the parameters used in serum screening for trisomy 21. Prenat Diagn 1995; 15: 781–782.

    Article  CAS  Google Scholar 

  13. Pepe GJ, Albrecht ED . Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995; 16: 608–648.

    CAS  PubMed  Google Scholar 

  14. Santolaya-Forgas J, Jessup J, Burd LI, Prins GS, Burton BK . Pregnancy outcome in women with low midtrimester maternal serum unconjugated oestriol. J Reprod Med 1996; 41: 87–90.

    CAS  PubMed  Google Scholar 

  15. Kowalczyk TD, Cabaniss ML, Cusmano L . Association of low unconjugated oestriol in the second trimester and adverse pregnancy outcome. Obstet Gynecol 1998; 91: 396–400.

    Article  CAS  Google Scholar 

  16. Benn PA, Craffey A, Horne D, Ramsdell L, Rodis JF . Elevated maternal serum alpha-fetoprotein with low unconjugated oestriol and the risk for lethal perinatal outcome. J Matern Fetal Med 2000; 9: 165–169.

    CAS  PubMed  Google Scholar 

  17. Schleifer RA, Bradley LA, Richards DS, Ponting NR . Pregnancy outcome for women with low levels of maternalserum unconjugated oestriol on second-trimester screening. Am J Obstet Gynecol 1995; 173: 1152–1156.

    Article  CAS  Google Scholar 

  18. Pasqualini JR, Kind FA . Hormone production and concentration during pregnancy in humans and in other mammalian species. In: Pasqualini JR (ed), Hormones and the Fetus. Pergamon Press: Oxford, 1985, pp 173–333.

    Google Scholar 

  19. Zbella EA, Ilekis J, Scommegna A, Benveniste R . Competitive studies with dehydroepiandrosterone sulphate and 16 alphahydroxydehydroepiandrosterone sulphate in cultured human choriocarcinoma JEG-3 cells: effect on estrone, 17 beta-estradiol, and estriol secretion. J Clin Endocrinol Metab 1986; 63: 751–757.

    Article  CAS  Google Scholar 

  20. Sancken U, Bartels I . Preliminary data on an association between blood groups and serum markers used for the so-called ‘triple screening’: free oestriol MoM values are decreased in rhesus-negative (Rhx) women. Prenat Diagn 2001; 21: 194–195.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Muhcu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muhcu, M., Mungen, E., Dundar, O. et al. Reliability of second trimester triple screening for Down syndrome in rhesus-negative women. J Perinatol 27, 268–271 (2007). https://doi.org/10.1038/sj.jp.7211681

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.jp.7211681

Keywords

Search

Quick links